Polar Asset Management Partners Inc. Lantheus Holdings, Inc. Transaction History

Polar Asset Management Partners Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $3.87 Million - $5.42 Million	-69,600 Reduced 85.19%	12,100 $750,000
Q3 2023 Nov 14, 2023	BUY	$60.27 - $90.75 $4.92 Million - $7.41 Million	81,700 New	81,700 $5.68 Million
Q4 2022 Feb 14, 2023	BUY	$48.76 - $77.67 $2.19 Million - $3.49 Million	44,900 New	44,900 $2.29 Million
Q2 2022 Aug 15, 2022	SELL	$55.54 - $72.65 $18.1 Million - $23.7 Million	-326,600 Reduced 37.12%	553,272 $36.5 Million
Q1 2022 May 16, 2022	SELL	$24.28 - $56.64 $12.4 Million - $29 Million	-512,000 Reduced 36.78%	879,872 $48.7 Million
Q4 2021 Feb 14, 2022	SELL	$22.54 - $30.44 $2.73 Million - $3.69 Million	-121,186 Reduced 8.01%	1,391,872 $40.2 Million
Q3 2021 Nov 15, 2021	BUY	$24.23 - $28.59 $15.1 Million - $17.9 Million	624,459 Added 70.27%	1,513,058 $38.9 Million
Q2 2021 Aug 16, 2021	BUY	$19.51 - $27.64 $17.3 Million - $24.6 Million	888,599 New	888,599 $24.6 Million

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.08B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.